Bausch Health Cos Gross Profit 2010-2024 | BHC
Bausch Health Cos gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Bausch Health Cos Annual Gross Profit (Millions of US $) |
2023 |
$6,198 |
2022 |
$5,760 |
2021 |
$6,040 |
2020 |
$5,778 |
2019 |
$6,251 |
2018 |
$6,029 |
2017 |
$6,176 |
2016 |
$7,063 |
2015 |
$7,862 |
2014 |
$5,970 |
2013 |
$3,865 |
2012 |
$2,511 |
2011 |
$1,731 |
2010 |
$775 |
2009 |
$602 |
Bausch Health Cos Quarterly Gross Profit (Millions of US $) |
2024-09-30 |
$1,814 |
2024-06-30 |
$1,684 |
2024-03-31 |
$1,513 |
2023-12-31 |
$1,703 |
2023-09-30 |
$1,615 |
2023-06-30 |
$1,518 |
2023-03-31 |
$1,362 |
2022-12-31 |
$1,541 |
2022-09-30 |
$1,462 |
2022-06-30 |
$1,390 |
2022-03-31 |
$1,367 |
2021-12-31 |
$1,570 |
2021-09-30 |
$1,529 |
2021-06-30 |
$1,488 |
2021-03-31 |
$1,453 |
2020-12-31 |
$1,568 |
2020-09-30 |
$1,548 |
2020-06-30 |
$1,169 |
2020-03-31 |
$1,493 |
2019-12-31 |
$1,589 |
2019-09-30 |
$1,625 |
2019-06-30 |
$1,558 |
2019-03-31 |
$1,479 |
2018-12-31 |
$1,519 |
2018-09-30 |
$1,554 |
2018-06-30 |
$1,534 |
2018-03-31 |
$1,422 |
2017-12-31 |
$1,516 |
2017-09-30 |
$1,560 |
2017-06-30 |
$1,587 |
2017-03-31 |
$1,513 |
2016-12-31 |
$1,738 |
2016-09-30 |
$1,821 |
2016-06-30 |
$1,762 |
2016-03-31 |
$1,742 |
2015-12-31 |
$2,028 |
2015-09-30 |
$2,139 |
2015-06-30 |
$2,047 |
2015-03-31 |
$1,648 |
2014-12-31 |
$1,651 |
2014-09-30 |
$1,495 |
2014-06-30 |
$1,456 |
2014-03-31 |
$1,368 |
2013-12-31 |
$1,332 |
2013-09-30 |
$967 |
2013-06-30 |
$798 |
2013-03-31 |
$768 |
2012-12-31 |
$702 |
2012-09-30 |
$654 |
2012-06-30 |
$610 |
2012-03-31 |
$544 |
2011-12-31 |
$499 |
2011-09-30 |
$435 |
2011-06-30 |
$436 |
2011-03-31 |
$362 |
2010-12-31 |
$301 |
2010-09-30 |
$146 |
2010-06-30 |
$172 |
2010-03-31 |
$157 |
2009-12-31 |
$168 |
2009-09-30 |
$162 |
2009-06-30 |
$143 |
2009-03-31 |
$128 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$2.672B |
$8.757B |
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|